179 related articles for article (PubMed ID: 34063472)
1. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
[TBL] [Abstract][Full Text] [Related]
2. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
3. Circulating microbiota-derived metabolites: a "liquid biopsy?
Aragonès G; Colom-Pellicer M; Aguilar C; Guiu-Jurado E; Martínez S; Sabench F; Antonio Porras J; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Obes (Lond); 2020 Apr; 44(4):875-885. PubMed ID: 31388096
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
[TBL] [Abstract][Full Text] [Related]
6. Increased Hepatic
Barrientos-Riosalido A; Real M; Bertran L; Aguilar C; Martínez S; Parada D; Vives M; Sabench F; Riesco D; Castillo DD; Richart C; Auguet T
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674839
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
[TBL] [Abstract][Full Text] [Related]
8. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
[TBL] [Abstract][Full Text] [Related]
9. New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.
Bertran L; Jorba-Martin R; Barrientos-Riosalido A; Portillo-Carrasquer M; Aguilar C; Riesco D; Martínez S; Vives M; Sabench F; Castillo DD; Richart C; Auguet T
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806447
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH).
Kaur S; Rawal P; Siddiqui H; Rohilla S; Sharma S; Tripathi DM; Baweja S; Hassan M; Vlaic S; Guthke R; Thomas M; Dayoub R; Bihari C; Sarin SK; Weiss TS
Cells; 2019 Oct; 8(10):. PubMed ID: 31635436
[TBL] [Abstract][Full Text] [Related]
11. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
[TBL] [Abstract][Full Text] [Related]
12. Expression of Jejunal Taste Receptors in Women with Morbid Obesity.
Bertran L; Portillo-Carrasquer M; Martínez S; Aguilar C; Lopez-Dupla M; Riesco D; Binetti J; Vives M; Sabench F; Del Castillo D; Richart C; Auguet T
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371946
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism.
Villar B; Bertran L; Aguilar C; Binetti J; Martínez S; Sabench F; Real M; Riesco D; París M; Del Castillo D; Richart C; Auguet T
Metabolites; 2021 Jun; 11(6):. PubMed ID: 34200577
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
Charlton M; Viker K; Krishnan A; Sanderson S; Veldt B; Kaalsbeek AJ; Kendrick M; Thompson G; Que F; Swain J; Sarr M
Hepatology; 2009 Apr; 49(4):1375-84. PubMed ID: 19330863
[TBL] [Abstract][Full Text] [Related]
16. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
18. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
Kapil S; Duseja A; Sharma BK; Singla B; Chakraborti A; Das A; Ray P; Dhiman RK; Chawla Y
J Gastroenterol Hepatol; 2016 Jan; 31(1):213-21. PubMed ID: 26212089
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
[TBL] [Abstract][Full Text] [Related]
20. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
